KRMD News
KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026
KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report...
Business Wire
KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026
KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report...
Business Wire
Reasons to Retain Doximity Stock in Your Portfolio for Now
DOCS' rapid clinical AI adoption and strong cash generation support its outlook, but tight pharma budgets and AI costs may limit near-term gains.
Zacks
KORU Medical Systems, Inc. (KRMD) Q2 Earnings and Revenues Beat Estimates
KORU Medical Systems, Inc. (KRMD) delivered earnings and revenue surprises of +150.00% and +2.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance
KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the...
Business Wire
KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference
KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will...
Business Wire
Kaskela Law LLC Announces Investigation of KORU Medical Systems, Inc. (KRMD) and Encourages Long-Term KRMD Shareholders to Contact the Firm
Kaskela Law is investigating KORU Medical Systems, Inc. (Nasdaq: KRMD) (KORU) on behalf of the companys current shareholders.The investigation seeks to determine whether KORU and/or the companys officers and directors violated the securities laws or breached their fiduciary duties in connection...
Business Wire
KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026
KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report...
Business Wire
KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress
KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions...
Business Wire
KORU Medical Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
KORU Medical Systems, Inc. (KRMD) delivered earnings and revenue surprises of -33.33% and +3.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
KORU Medical Systems Announces First Quarter 2026 Results
KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and...
Business Wire